BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smith AF, Shinkins B, Hall PS, Hulme CT, Messenger MP. Toward a Framework for Outcome-Based Analytical Performance Specifications: A Methodology Review of Indirect Methods for Evaluating the Impact of Measurement Uncertainty on Clinical Outcomes. Clin Chem 2019;65:1363-74. [PMID: 31444309 DOI: 10.1373/clinchem.2018.300954] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Rabe C, Bittner T, Jethwa A, Suridjan I, Manuilova E, Friesenhahn M, Stomrud E, Zetterberg H, Blennow K, Hansson O; Alzheimer's Disease Neuroimaging Initiative† and the Swedish BioFINDER study. Clinical performance and robustness evaluation of plasma amyloid-β42/40 prescreening. Alzheimers Dement 2022. [PMID: 36150024 DOI: 10.1002/alz.12801] [Reference Citation Analysis]
2 White S, Gong H, Zhu L, Doust J, Loh TP, Lord S, Andrea ARH, Mcgeechan K, Bell K. Simulations found within-subject measurement variation in glycaemic measures may cause overdiagnosis of prediabetes and diabetes. Journal of Clinical Epidemiology 2021. [DOI: 10.1016/j.jclinepi.2021.12.025] [Reference Citation Analysis]
3 Ferraro S, Biganzoli EM. The clinical value of assessing the inter-method bias: the lesson from prostate specific antigen measurement. Clin Chem Lab Med 2021. [PMID: 34751521 DOI: 10.1515/cclm-2021-1125] [Reference Citation Analysis]
4 Loh TP, Smith AF, Bell KJL, Lord SJ, Ceriotti F, Jones G, Bossuyt P, Sandberg S, Horvath AR. Setting analytical performance specifications using HbA1c as a model measurand. Clin Chim Acta 2021;523:407-14. [PMID: 34666026 DOI: 10.1016/j.cca.2021.10.016] [Reference Citation Analysis]
5 Braga F, Panteghini M. Performance specifications for measurement uncertainty of common biochemical measurands according to Milan models. Clin Chem Lab Med 2021. [PMID: 33725754 DOI: 10.1515/cclm-2021-0170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Chatzimichail T, Hatjimihail AT. A Software Tool for Calculating the Uncertainty of Diagnostic Accuracy Measures. Diagnostics (Basel) 2021;11:406. [PMID: 33673466 DOI: 10.3390/diagnostics11030406] [Reference Citation Analysis]
7 Ferraro S, Bussetti M, Panteghini M. Serum Prostate-Specific Antigen Testing for Early Detection of Prostate Cancer: Managing the Gap between Clinical and Laboratory Practice. Clin Chem 2021;67:602-9. [PMID: 33619518 DOI: 10.1093/clinchem/hvab002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Augustovski F, Alfie V, Alcaraz A, García Martí S, Drummond MF, Pichon-Riviere A. A Value Framework for the Assessment of Diagnostic Technologies: A Proposal Based on a Targeted Systematic Review and a Multistakeholder Deliberative Process in Latin America. Value Health 2021;24:486-96. [PMID: 33840426 DOI: 10.1016/j.jval.2020.11.008] [Reference Citation Analysis]
9 Xia Y, Li M, Li B, Xue H, Lin Y, Li J, Ji L. Sigma metrics application for validated and non-validated detecting systems performance assessment. J Clin Lab Anal 2021;35:e23676. [PMID: 33314338 DOI: 10.1002/jcla.23676] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Chatzimichail T, Hatjimihail AT. A Software Tool for Exploring the Relation between Diagnostic Accuracy and Measurement Uncertainty. Diagnostics (Basel) 2020;10:E610. [PMID: 32825135 DOI: 10.3390/diagnostics10090610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]